Egypt Secures 20 Million Doses of Russia's New Coronavirus Vaccine

On September 30, 2020, the Russian Direct Investment Fund and the Pharco pharmaceutical groups in Egypt (Biogeneric Pharma) announced an agreement to secure the supply of 25 million doses of the Sputnik V vaccine to Egypt.

This new agreement will enable 25% of Egypt’s population to have access to the Sputnik V vaccine. In the future, it is planned to distribute Sputnik V to neighboring countries, stated this press release.